TSS, Inc. Insider Report: CFO Disposes of 15,000 TSSI Shares
Rhea-AI Filing Summary
Daniel M. Chism, listed as Chief Financial Officer of TSS, Inc. (TSSI), reported sales of company common stock on 08/27/2025 and 08/28/2025. The Form 4 shows a sale of 10,000 shares on 08/27/2025 at a weighted average price of $16.25 and a sale of 5,000 shares on 08/28/2025 at $16.20. The report records beneficial ownership of 316,219 shares following the 08/27 sale and 311,219 shares following the 08/28 sale. The filing is signed by an attorney-in-fact, Christopher R. Johnson, dated 08/29/2025. The filer affirms willingness to provide transaction-level price details within the disclosed price range.
Positive
- Timely disclosure: Form 4 was filed with signature dated 08/29/2025, providing required insider sale reporting.
- Detailed pricing footnote: The filer offers to supply per-trade prices within the disclosed weighted-average range, enhancing transparency.
Negative
- Officer dispositions: The Chief Financial Officer sold a total of 15,000 shares across two days, reducing reported beneficial ownership from 316,219 to 311,219 after the second sale.
- No indication of plan-based sales: The form does not indicate these sales were made pursuant to a Rule 10b5-1 plan, which some investors use to reduce concerns about timing.
Insights
TL;DR: Company CFO sold 15,000 TSSI shares across two days; filings disclose post-sale ownership and weighted average sale prices.
The Form 4 documents two non-derivative dispositions by CFO Daniel M. Chism totaling 15,000 common shares executed on 08/27/2025 and 08/28/2025. Reported prices are a weighted average of $16.25 for the first date and $16.20 for the second; the filer notes transaction prices ranged from $16.245 to $16.26 for the 08/27 sales. Beneficial ownership is recorded as 316,219 shares after the 08/27 sale and 311,219 after the 08/28 sale. The filing is executed by an attorney-in-fact on 08/29/2025, indicating formal disclosure compliance. No other transactions, derivates, or plan-based sales are disclosed in this Form 4.
TL;DR: Insider sales were disclosed promptly and show a modest reduction in CFO's holdings; no derivative activity or plan-based sale indicated.
The filing indicates straightforward open-market dispositions rather than exercises or derivative transactions. The report includes a disclosure footnote offering to provide per-trade price details, which increases transparency. There is no evidence in this filing of Rule 10b5-1 plan sales or of any unusual related-party transactions. Based solely on the Form 4 content, the transaction appears to be a routine sale by an officer with post-transaction holdings clearly stated.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $16.20 | $81K |
| Sale | Common Stock | 10,000 | $16.25 | $163K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.245 to $16.26, inclusive. The reporting person undertakes to provide to TSS, Inc., any security holder of TSS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
FAQ
What transactions did TSSI insider Daniel M. Chism report on Form 4?
Was the Form 4 filed and signed, and by whom?
Are the reported sale prices exact per-trade figures?
Do these entries indicate sales under a 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.
